< Back to previous page
Researcher
Steven Joniau
- Disciplines:Urology and nephrology
Affiliations
- Urogenital, Abdominal and Plastic Surgery (Division)
Member
From1 Jan 2019 → Today - Woman and Child (Division)
Member
From1 Apr 2013 → 31 Dec 2018
Projects
1 - 10 of 19
- Improvement of therapeutic management in patients with high-risk and oligorecurrent prostate cancerFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Development of treatment intensification strategies for high-risk prostate cancer based on clinicopathological and molecular modeling, with the aim of delivering precision medicine to the individual patient.From1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The role of stromal components in urothelial cancerFrom4 Oct 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- New insights in the genomic architecture and treatment of high risk and oligometastatic prostate cancerFrom10 Sep 2021 → 30 Sep 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- Metastasis-directed therapy in castration-refractory prostate cancer (MEDCARE)From24 Sep 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Classical and non-classical actions of androgens and their receptorFrom1 Oct 2019 → 30 Sep 2023Funding: IOF - technology concept exploration, BOF - projects
- Fellowship: Optimization patient treatment pathway by combining genotypic and phenotypic data.From17 Dec 2018 → 16 Dec 2019Funding: Private funding of national origin - undefined
- Novel insights in the definition and treatment of high risk and oligometastatic prostate cancerFrom1 Oct 2018 → 18 Nov 2022Funding: FWO fellowships
- Traveling the prostate cancer timeline in chase of treatment paradigms Can we cure the incurable?From1 Aug 2017 → 1 Oct 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a better stratification of intermediate- and high-risk non-muscle-invasive bladder cancer patientsFrom1 Sep 2016 → 1 Sep 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
21 - 30 of 539
- Surgical Metastasectomy for Visceral and Bone Prostate Cancer Metastases: A Mini-Review(2023)
Authors: Steven Joniau
Pages: 232 - 235 - Predicting short- and long-term renal function following partial and radical nephrectomy(2023)
Authors: Annouschka Laenen, Ben Van Cleynenbreugel, Ben Sprangers, Benoit Beuselinck, Hendrik Van Poppel, Steven Joniau, Maarten Albersen
Pages: 1100 - 110000000 - International Multi-institutional Characterization of the Perioperative Morbidity of Metastasectomy for Renal Cell Carcinoma(2023)
Authors: Steven Joniau, Maarten Albersen
Pages: 76 - 83 - Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments(2023)
Authors: Steven Joniau
Pages: 110 - 118 - Defining the optimal template of salvage lymph node dissection for unilateral pelvic nodal recurrence of prostate cancer following radical prostatectomy(2023)
Authors: Gaëtan Devos, Charlien Berghen, Wouter Everaerts, Gert De Meerleer, Steven Joniau
Pages: 92 - 99 - Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer(2023)
Authors: Steven Joniau, Hendrik Van Poppel
Pages: 123 - 129 - Early biomarkers of extracapsular extension of prostate cancer using MRI-derived semantic features(2022)
Authors: Steven Joniau
- Long-term consequences of bilateral cavernous crush injury in normal and diabetic rats: a functional study(2022)
Authors: Maarten Albersen, Steven Joniau
Pages: 781 - 785 - Novel strategies in the management of high-risk and oligometastatic prostate cancer(2022)
Authors: Gaëtan Devos, Steven Joniau, Wouter Everaerts, Gert De Meerleer
- Treatment of patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) in Belgium: a real world data analysis(2022)
Authors: Steven Joniau
Pages: 897 - 905